Epigenetic reprogramming of cancer cells via targeted DNA methylation.
about
Enabling functional genomics with genome engineeringStrategies for precision modulation of gene expression by epigenome editing: an overviewThe complexity of epigenetic diseasesEpigenome engineering in cancer: fairytale or a realistic path to the clinic?The epigenome: the next substrate for engineeringEditing the Neuronal Genome: a CRISPR View of Chromatin Regulation in Neuronal Development, Function, and PlasticityCRISPR-Cas9: Tool for Qualitative and Quantitative Plant Genome EditingEpigenetic Editing: On the Verge of Reprogramming Gene Expression at WillChromatin regulation at the frontier of synthetic biologyLocal chromatin microenvironment determines DNMT activity: from DNA methyltransferase to DNA demethylase or DNA dehydroxymethylaseEpigenomics and allergic diseaseTargeted methylation of the epithelial cell adhesion molecule (EpCAM) promoter to silence its expression in ovarian cancer cellsTargeted DNA methylation in pericentromeres with genome editing-based artificial DNA methyltransferase.TGF-β mediated DNA methylation in prostate cancer.Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers.Synthetic zinc finger proteins: the advent of targeted gene regulation and genome modification technologies.Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation.Complementation between inactive fragments of SssI DNA methyltransferase.Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins.Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter.New approaches to manipulating the epigenome.Writing and rewriting the epigenetic code of cancer cells: from engineered proteins to small moleculesIdentification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma.Epigenetics of discordant monozygotic twins: implications for diseaseCan genome engineering be used to target cancer-associated enhancers?Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.Directed evolution of improved zinc finger methyltransferases.Predicting genome-wide DNA methylation using methylation marks, genomic position, and DNA regulatory elements.Genetically engineered pig models for human diseases.TALE-mediated epigenetic suppression of CDKN2A increases replication in human fibroblasts.Manipulation of prostate cancer metastasis by locus-specific modification of the CRMP4 promoter region using chimeric TALE DNA methyltransferase and demethylase.TALEored Epigenetics: A DNA-Binding Scaffold for Programmable Epigenome Editing and Analysis.Targeted silencing of the oncogenic transcription factor SOX2 in breast cancerProlonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugsStable oncogenic silencing in vivo by programmable and targeted de novo DNA methylation in breast cancer.P16-specific DNA methylation by engineered zinc finger methyltransferase inactivates gene transcription and promotes cancer metastasis.Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elementsEpigenetic Editing: targeted rewriting of epigenetic marks to modulate expression of selected target genes.Predicting DNA Methylation State of CpG Dinucleotide Using Genome Topological Features and Deep Networks.Breaking through an epigenetic wall: re-activation of Oct4 by KRAB-containing designer zinc finger transcription factors.
P2860
Q26782747-9C34286A-0E54-480C-B1D5-C0BE624A65E1Q26782876-88DFB08C-1D5F-4F51-BC5E-D3B156615093Q26784416-E4829498-B67C-4138-9204-7E03916B330CQ26861350-37AEB454-0095-4D99-9F79-656A5FF53A76Q28068278-96BC9B3D-ADDD-4287-A09E-23EF8B0F120BQ28075883-F302CFF4-3F19-49E3-81A1-522AE83F1250Q28079519-C58B99E6-956B-43FE-BD63-68B8C0769264Q28080188-978D9641-3578-44DF-8023-052BE4DC45DBQ28083608-58BDC4BF-9571-4698-8BC2-C871B5A6DF41Q28084375-788966A2-FBFF-4C0D-A93C-21B12005C51EQ28397508-9FD8C53B-5506-4E27-9CF1-CE9FA7E8376CQ31149698-2F0607FE-7418-466B-A3F1-D24B929CFF4CQ33703762-D0DA345E-BE0E-466A-B915-43E05D384978Q34039935-D311F07A-139A-4AFC-BDA4-2CB772409A61Q34043681-6827A1C2-1B34-4B82-8615-BDDFDABF9CCCQ34070213-BF3F93CA-091F-4013-A158-74AC747CD454Q34249565-31F3F0E8-94A4-49B6-9F2A-8F5D78BD38C8Q34286126-6D62CF51-A1F7-4373-8A36-BD1F79D1B1B7Q34376497-6B7E24C6-BBB0-4870-98B1-9DBAED256391Q34382768-A13C0007-CB62-45F4-B830-6D20F3A6CB41Q34426205-0935E8B3-CDC0-4D89-8336-A6A46BC1AE93Q34476349-A2238ECC-E99B-4FB6-8A58-4E5D417F2350Q34590776-75922AC7-EEDC-4DF7-AA86-17506EC283CDQ34624829-EDB317E9-8B1E-4D61-BB91-F950754258E4Q34652242-AE7CF868-6C29-4282-87A1-C3BC3446188FQ35000789-8C29AFE3-9E29-4F03-8D62-24A5F50BC2EAQ35165535-DE29CC3A-3DE1-443F-B486-CBC9C02CE24BQ35319065-C5C54502-29C6-4E50-8823-2B495713DC39Q35700104-0B79706F-3883-41FF-873F-DB47519A54B0Q35719892-AF024366-3C9D-4025-A987-EEE46B7C122BQ35832904-3294E8E9-9A69-46AC-A238-76E5B1FD7DABQ35955504-FF210114-425B-45E7-B57F-D1E4C86FCA25Q36144913-9AF68B6F-2561-4351-853C-3AE0F6776138Q36212723-111F1C42-1201-4DE7-BE79-0B9B26B4AC5EQ36249272-B7BB364D-0A16-4DBB-82AD-04B4E0E6B8F7Q36307848-F6E88D6B-6C5D-4A03-BF0D-6807AB541E18Q36338669-3979AFD6-FDCD-420C-8FDF-6B750D10EA49Q36435079-D98FC0E2-1689-43F2-B5CB-BB3DA4E8536FQ36501173-D94D704C-2D7C-41C2-AFBA-6D12958244B8Q36669986-72DB735C-654C-498F-84AA-BD3CCE7851A0
P2860
Epigenetic reprogramming of cancer cells via targeted DNA methylation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Epigenetic reprogramming of cancer cells via targeted DNA methylation.
@ast
Epigenetic reprogramming of cancer cells via targeted DNA methylation.
@en
type
label
Epigenetic reprogramming of cancer cells via targeted DNA methylation.
@ast
Epigenetic reprogramming of cancer cells via targeted DNA methylation.
@en
prefLabel
Epigenetic reprogramming of cancer cells via targeted DNA methylation.
@ast
Epigenetic reprogramming of cancer cells via targeted DNA methylation.
@en
P2093
P2860
P356
P1433
P1476
Epigenetic reprogramming of cancer cells via targeted DNA methylation
@en
P2093
Adriana S Beltran
Ashley G Rivenbark
Marianne G Rots
Sabine Stolzenburg
Xinni Yuan
P2860
P304
P356
10.4161/EPI.19507
P577
2012-04-01T00:00:00Z